Federal Register / Vol. 60, No. 82 / Friday, April 28, 1995 / Notices 20997

time for submission to the objective

review group. (The applicants must

request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or the U.S. Postal Service. Private

metered postmarks shall not be

acceptable as proof of timely mailing.)

2. Late Applicants: Applications that

do not meet the criteria in 1.(a) or 1.(b)

above are considered late applications.

Late applications will not be considered

in the current competition and will be

returned to the applicants.

Where to Obtain Additional

Information

To receive additional written

information call (404) 332–4561. You

will be asked to leave your name,

address, and telephone number and will

need to refer to Announcement 528.

You will be receive a complete program

description, information on application

procedures, and application forms.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from Oppie

M. Byrd, Grants Management Specialist,

Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E–13, Atlanta, GA

30305, telephone (404) 842–6546.

Programmatic technical assistance may

be obtained from Marie Haring

Sweeney, Ph.D., National Institute for

Occupational Safety and Health,

Division of Surveillance, Hazard

Evaluation and Field Studies, Centers

for Disease Control and Prevention

(CDC), Mailstop R–13, Robert A. Taft

Laboratories, 4676 Columbia Parkway,

Cincinnati, OH 45226–1049, telephone

(513) 841–4207.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) referenced

in the INTRODUCTION through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

Copies of A Framework for Assessing

the Effectiveness of Disease and Injury

Prevention (CDC, Morbidity and

Mortality Weekly Report, March 27,

1992, Volume 41, Number RR–3, pages

5–11) may be obtained by calling (404)

488–4334.

Dated: April 21, 1995.

Diane D. Porter,

Acting Director, National Institute for

Occupational Safety and Health, Centers for

Disease Control and Prevention.

[FR Doc. 95–10454 Filed 4–27–95; 8:45 am]

BILLING CODE 4163–19–P

Food and Drug Administration

[Docket No. 95C–0091]

GNT Gesellshaft fu ̈r

Nahrungsmitteltechnologie mbH;

Filing of Color Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that GNT Gesellshaft fu ̈r

Nahrungsmitteltechnologie mbH has

filed a petition proposing that the color

additive regulations be amended to

provide for the safe use of dried fruit

juice color additive, dried vegetable

juice color additive, and vegetable juice

color additive prepared by water

infusion of the dried vegetable.

FOR FURTHER INFORMATION CONTACT:

Aydin O ̈ rstan, Center for Food Safety

and Applied Nutrition (HFS–217), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3076.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 721(b)(5) (21 U.S.C. 379e(b)(5))),

notice is given that a color additive

petition (CAP 5C0245) has been filed by

GNT Gesellshaft fu ̈r

Nahrungsmitteltechnologie mbH, c/o

Burditt & Radzius, Chtd., 333 West

Wacker Dr., suite 2600, Chicago, IL

60606–1218. The petition proposes to

amend the color additive regulations in

§ 73.250 Fruit juice (21 CFR 73.250) to

provide for the safe use of dried fruit

juice color additive and in § 73.260

Vegetable juice (21 CFR 73.260) to

provide for the safe use of dried

vegetable juice color additive, and

vegetable juice color additive prepared

by water infusion of the dried vegetable.

The agency has determined under 21

CFR 25.24(a)(9) that this action is of a

type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

Dated: April 20, 1995.

Alan M. Rulis,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 95–10539 Filed 4–27–95; 8:45 am]

BILLING CODE 4160–01–F

[Docket No. 93N–0418]

United Blood Services Blood Systems,

Inc.; Revocation of U.S. License No.

0183–020

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing the

revocation of the establishment license

(U.S. License No. 0183–020) and

product licenses issued to United Blood

Services Blood Systems, Inc. (BSI), for

the manufacture of Whole Blood (ACD,

CPD, CPDA–1), Red Blood Cells, Red

Blood Cells Leukocytes Removed,

Plasma, Fresh Frozen Plasma,

Cryoprecipitated AHF, Platelets,

Platelets Pheresis, and Source

Leukocytes. BSI has numerous locations

throughout the United States; the

licenses have been revoked only at the

BSI location at Texarkana, TX. In a letter

to FDA dated June 28, 1993, BSI

voluntarily requested the revocation of

its establishment and product licenses

and waived its opportunity for hearing.

DATES: The revocation of the

establishment license (U.S. License No.

0183–020) and the product licenses

became effective July 23, 1993.

FOR FURTHER INFORMATION CONTACT: Jean

M. Olson, Center for Biologics

Evaluation and Research (HFM–635),

Food and Drug Administration, 1401

Rockville Pike, Rockville, MD 20852–

1448, 301–594–3074.

SUPPLEMENTARY INFORMATION: FDA is

announcing the revocation of the

establishment license (U.S. License No.

0183–020) and the product licenses

issued to BSI, 1321 College Dr.,

Texarkana, TX 75503, for the

manufacture of Whole Blood (ACD,

CPD, CPDA–1), Red Blood Cells, Red

Blood Cells Leukocytes Removed,

Plasma, Fresh Frozen Plasma,

Cryoprecipitated AHF, Platelets,

Platelets Pheresis, and Source

Leukocytes. The current mailing address

is United Blood Services Blood Systems,

Inc., c/o Blood Systems, Inc., 6210 East

Oak St., P.O. Box 1867, Scottsdale, AZ

85252. BSI has numerous locations

throughout the United States. The

licenses were revoked for the

Texarkana, TX, location only.